?Nadifloxacin (CAS 124858-35-1)?
?? ?ChemicalBook Product Introduction?

?? ?Product Overview?

?Nadifloxacin? is a broad-spectrum fluoroquinolone antibiotic with the molecular formula ?C19H21FN2O4?. It effectively inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and synthesis, making it ideal for treating ?skin infections? such as acne vulgaris, folliculitis, and impetigo. Available as a white to off-white crystalline powder, it offers a purity of ?≥98% (HPLC verified)? and remains stable under recommended storage conditions (?0-8°C or -20°C?).

?Google Keywords?: Nadifloxacin CAS 124858-35-1, High-Purity Antibiotic Powder, Acne Treatment API, Topical Skin Infection Solution

? ?Key Advantages?

      ?? ?High Purity & Stability?

• Purity ≥98% (HPLC/UV verified) | Stable for long-term storage at ?-20°C? or ?0-8°C?.
  ?? ?Broad-Spectrum Antibacterial Action?

• Targets Gram-positive/negative bacteria and anaerobic strains | ?IC50 <0.1 μg/mL? against Propionibacterium acnes.
  ?? ?Topical Safety & Efficacy?

• Minimizes systemic side effects | Clinically proven to reduce inflammatory acne lesions.
  ?? ?Global Compliance?

• Meets ?EP/CP/USP? standards | Produced in ?GMP-certified facilities?.

?? ?Application Fields?

• ?Dermatology?: Treatment of acne vulgaris, folliculitis, and impetigo.

• ?Topical Formulations?: Key ingredient in creams, gels, and ointments for bacterial skin infections.

• ?Research?: Antibacterial mechanism studies and formulation development.

?? ?Quality Certifications?

• ?Testing Methods?: HPLC, NMR, MS, and microbial limit testing.

• ?Certifications?: ISO 9001, GMP compliance, and FDA-aligned quality systems.

?? ?Market Trends?

The global ?acne treatment market? is projected to grow at ?4.2% CAGR (2025-2030)?, driven by rising antibiotic-resistant skin infections. Nadifloxacin’s efficacy against C. acnes positions it as a critical component in topical antibiotic demand, particularly in Asia-Pacific regions.